BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Liver cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
78 results:

  • 1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
    Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
    Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Characterization of lymphocyte-rich hepatocellular carcinoma and the prognostic role of tertiary lymphoid structures.
    Ahn B; Ahn HS; Shin J; Jun E; Koh EY; Ryu YM; Kim SY; Sung CO; Shim JH; Hong J; Kim K; Kang HJ
    Liver Int; 2024 May; 44(5):1202-1218. PubMed ID: 38363048
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The 'Other' subfamily of HECT E3 ubiquitin ligases evaluate the tumour immune microenvironment and prognosis in patients with hepatocellular carcinoma.
    Dong R; Wang Z; Cao D; Li Y; Fei Y; Gao P; Zhu M; Chen Z; Cai J; Zuo X
    IET Syst Biol; 2024 Feb; 18(1):23-39. PubMed ID: 38318939
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Association of Immune Cell Infiltration with Metastasis Location in De Novo Metastatic Triple Negative Breast cancer: A Multicenter Cross-Sectional Study in Indonesia.
    Tenggara JB; Rachman A; Prihartono J; Lisnawati L; Panigoro SS; Heriyanto DS; Steven R; Tandarto K; Juanputra S; Sudoyo AW
    Acta Med Indones; 2023 Oct; 55(4):376-384. PubMed ID: 38213050
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Prognostic value and distribution pattern of tumor infiltrating lymphocytes and their subsets in distant metastases of advanced breast cancer.
    Sun XY; Wang CQ; Mao Y; Zhang ZQ; Cui J; Dong XN; Wang HB
    Clin Breast Cancer; 2024 Apr; 24(3):e167-e176. PubMed ID: 38212189
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Increased co-expression of PD1 and TIM3 is associated with poor prognosis and immune microenvironment heterogeneity in gallbladder cancer.
    He X; Peng Y; He G; Ye H; Liu L; Zhou Q; Shi J; Fu S; Wang J; Zhou Z; Li W
    J Transl Med; 2023 Oct; 21(1):717. PubMed ID: 37828574
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The necroptosis related gene LGALS3 can be used as a biomarker for the adverse progression from chronic HBV infection to HCC.
    Dong J; Zhang R; Xia Y; Jiang X; Zhou K; Li J; Guo M; Cao X; Zhang S
    Front Immunol; 2023; 14():1142319. PubMed ID: 37180150
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Chromosome 11q13 amplification correlates with poor response and prognosis to PD-1 blockade in unresectable hepatocellular carcinoma.
    Yan K; Zhang D; Chen Y; Lu W; Huang M; Cai J; Chen S; Bei T; Bai Y; Lv J; Fu Y; Zhang H
    Front Immunol; 2023; 14():1116057. PubMed ID: 37056769
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. A Deep-Learning-Computed cancer Score for the Identification of Human Hepatocellular Carcinoma Area Based on a Six-Colour Multiplex Immunofluorescence Panel.
    Dievernich A; Stegmaier J; Achenbach P; Warkentin S; Braunschweig T; Neumann UP; Klinge U
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048147
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Integrative analyses identify CD73 as a prognostic biomarker and immunotherapeutic target in intrahepatic cholangiocarcinoma.
    Sun BY; Yang ZF; Wang ZT; Liu G; Zhou C; Zhou J; Fan J; Gan W; Yi Y; Qiu SJ
    World J Surg Oncol; 2023 Mar; 21(1):90. PubMed ID: 36899373
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. foxp3 and SQSTM1/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma.
    Liu S; Zhang H; Yan J; Zhu J; Bai Z; Li X
    Pathol Res Pract; 2023 Feb; 242():154292. PubMed ID: 36630868
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Single-Cell Landscape of Intratumoral Heterogeneity and The Immunosuppressive Microenvironment in liver and Brain Metastases of Breast cancer.
    Zou Y; Ye F; Kong Y; Hu X; Deng X; Xie J; Song C; Ou X; Wu S; Wu L; Xie Y; Tian W; Tang Y; Wong CW; Chen ZS; Xie X; Tang H
    Adv Sci (Weinh); 2023 Feb; 10(5):e2203699. PubMed ID: 36529697
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Immune Evasion and Drug Resistance Mediated by USP22 in cancer: Novel Targets and Mechanisms.
    Guo J; Zhao J; Fu W; Xu Q; Huang D
    Front Immunol; 2022; 13():918314. PubMed ID: 35935969
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. DKK1 drives immune suppressive phenotypes in intrahepatic cholangiocarcinoma and can be targeted with anti-DKK1 therapeutic DKN-01.
    Jarman EJ; Horcas-Lopez M; Waddell SH; MacMaster S; Gournopanos K; Soong DYH; Musialik KI; Tsokkou P; Ng ME; Cambridge WA; Wilson DH; Kagey MH; Newman W; Pollard JW; Boulter L
    Liver Int; 2023 Jan; 43(1):208-220. PubMed ID: 35924447
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. C-reactive protein/albumin ratio and Glasgow prognostic score are associated with prognosis and infiltration of foxp3+ or CD3+ lymphocytes in colorectal liver metastasis.
    Kanno H; Hisaka T; Akiba J; Hashimoto K; Fujita F; Akagi Y
    BMC Cancer; 2022 Aug; 22(1):839. PubMed ID: 35915403
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Metformin modulate immune fitness in hepatocellular carcinoma: Molecular and cellular approach.
    Abd El-Fattah EE; Zakaria AY
    Int Immunopharmacol; 2022 Aug; 109():108889. PubMed ID: 35679661
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The role of tumor-infiltrating lymphocytes in cholangiocarcinoma.
    Liu D; Heij LR; Czigany Z; Dahl E; Lang SA; Ulmer TF; Luedde T; Neumann UP; Bednarsch J
    J Exp Clin Cancer Res; 2022 Apr; 41(1):127. PubMed ID: 35392957
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Integrative analysis identifies activated anti-tumor immune microenvironment in lung metastasis of pancreatic cancer.
    Sasaki T; Nishiwada S; Nakagawa K; Nagai M; Terai T; Hokuto D; Yasuda S; Matsuo Y; Doi S; Sho M
    Int J Clin Oncol; 2022 May; 27(5):948-957. PubMed ID: 35142963
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Leukocytes infiltration correlates intratumoral microvessel density and influence overall and late-phase disease-free survival in hepatocellular carcinoma.
    Yang Y; Fu N; Wang H; Hao J
    Medicine (Baltimore); 2021 Dec; 100(48):e28135. PubMed ID: 35049245
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. PD-L1
    Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
    Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 4.